The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme

Journal of Nuclear Medicine

Volumn 51, Issue 12, 2010, Pages 1923-1926

  Alexiou, George A ^a   Tsiouris, Spyridon ^a   Kyritsis, Athanasios P ^a   Fotakopoulos, George ^a   Goussia, Anna ^a   Voulgaris, Spyridon ^a   Fotopoulos, Andreas D ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

99mTc tetrofosmin; Brain SPECT; Glioblastoma multiforme; Survival

Indexed keywords

TEMOZOLOMIDE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; KI 67 ANTIGEN; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NEUROSURGERY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; BRAIN; BRAIN TUMOR; COMPUTER ASSISTED DIAGNOSIS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; PREDICTIVE VALUE; SCINTISCANNING; SURVIVAL;

AGED; BRAIN; BRAIN NEOPLASMS; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; KI-67 ANTIGEN; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 78651338642     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.080929     Document Type: Article

References (21)

1. Scott JN, Rewcastle NB, Brasher PM, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol. 1999;46:183-188.
2. Liu Y, Shete S, Etzel CJ, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol. 2010;28:2467-2474.
3. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-198.
4. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85:704-710.
5. Shinojima N, Kochi M, Hamada J, et al. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg. 2004;101:219-226.
6. McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068.
7. Schwartz RB, Holman BL, Polak JF, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg. 1998;89:60-68.
8. 123I] iodo-L-α-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med. 2001;42:1144-1150.
9. Alexiou GA, Tsiouris S, Kyritsis AP, et al. Assessment of gliomas proliferation by imaging modalities. J Clin Neurosci. 2010;17:1233-1238.
10. 99mTc-tetrofosmin. Neuro Oncol. 2008;10:104-105.
11. 99mTc-tetrofosmin SPECT uptake. Clin Neurol Neurosurg. 2009;111:808-811.
12. Faria MH, Gonçalves BP, do Patrocínio RM, de Moraes-Filho MO, Rabenhorst SH. Expression of Ki-67, topoisomerase IIa and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Neuropathology. 2006;26:519-527.
13. 18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol. 1987;22:360-371.
14. Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med. 1993;34:2085-2089.
15. 99mTc-tetrofosmin. Ann Nucl Med. 2004;18:79-95.
16. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med. 2004;45:409-413.
17. Soricelli A, Cuocolo A, Varrone A, et al. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. J Nucl Med. 1998;39:802-806.
18. 99mTc-tetrofosmin uptake. Mol Imaging Biol. June 15, 2010 [Epub ahead of print].
19. 99mTc-tetrofosmin SPECT: a prospective pilot study. Ann Nucl Med. 2007;21:293-298.
20. Fotopoulos AD, Kyritsis AP, Tsiouris S, et al. Characterization of intracranial spaceoccupying lesions by 99mTc-tetrofosmin SPECT. J Neurooncol. 2010 May 23.
21. 99mTc-tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index. J Neurooncol. 2008;89:225-230.